Afya 有限公司

最新新闻

• 评级变动
  BofA Securities Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/4/22
• 评级变动
  J.P. Morgan Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/1/7
• Press Release: Afya Limited and Yduqs Participações S.A. Enter Into Merger Agreement
  Dow Jones · 2026/9/24
• 公司公告
  Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nicolau Carvalho Esteves(17.4%),Rosângela de Oliveira Tavares Esteves(17.4%), etc.
  SEC · 2024/11/15
• 公司公告
  Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lílian Tavares Esteves de Carvalho(3.3%),LTE B Ventures Limited(3.3%), etc.
  SEC · 2024/11/15
• 评级变动
  UBS Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/1/16
• J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21.5
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• 公司公告
  Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renato Tavares Esteves(3.3%),RTE B Ventures Limited(3.3%), etc.
  SEC · 2024/11/15
• 评级变动
  BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/11/13
• J.P. Morgan Maintains Afya Ltd(AFYA.US) With Hold Rating, Cuts Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• 评级变动
  UBS Maintains Afya Ltd(AFYA.US) With Buy Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/1/8
• 公司公告
  Afya Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vanessa Tavares Esteves(3.1%),VTE B Ventures Limited(3.1%), etc.
  SEC · 2024/11/15
• 公司公告
  Afya Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lílian Tavares Esteves de Carvalho(3.3%),LTE B Ventures Limited(3.3%), etc.
  SEC · 2024/11/15
• 评级变动
  BTG Pactual Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/1/21
• Afya GAAP EPS of R$2.22 Beats by R$1.85, Revenue of R$972M
  Seeking Alpha · 2026/8/14
• 评级变动
  Morgan Stanley Downgrades Afya Ltd(AFYA.US) to Hold Rating, Maintains Target Price $17.5
  \u5e02\u573a\u8d44\u8baf · 2025/11/13
• 评级变动
  BofA Securities Downgrades Afya Ltd(AFYA.US) to Hold Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/2/24
• J.P. Morgan Upgrades Afya Ltd(AFYA.US) to Buy Rating, Cuts Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  UBS Maintains Afya Ltd(AFYA.US) With Hold Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/1/16
• 评级变动
  BofA Securities Maintains Afya Ltd(AFYA.US) With Buy Rating, Announces Target Price $22
  \u5e02\u573a\u8d44\u8baf · 2025/12/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。